RxDoctor Payments Data

Tung Ngo

Internal Medicine · Newport Beach, CANPI 1104095256

Payments from drug & device makers

What this record shows

This record is dominated by other: $4,866,713 of the $4,868,399 with a category attached, or 100.0%. Medtronic accounts for 100.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $4,840,799 and has fallen 100.0% since, to $838 in 2025. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,868,399in general payments, 2019–2025

Across 18 payments — averaging $270,467 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4.9M
  • Amgen$417
  • Abbott$323
  • Pfizer$241
  • Abiomed$137
  • AstraZeneca$124
  • plus $443 from 4 others

What the payments were for

  • Food & beverage$1,6860%
  • Other$4,866,713100%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,868,399 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Other internal medicine in Newport Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →